{"disease":{"id":"de-novo-kidney-transplant-patients","name":"de novo kidney transplant patients"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02267512","title":"Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}